Chinese Journal of Pharmacovigilance ›› 2018, Vol. 15 ›› Issue (4): 255-256.
WANG Wei-bo1, WANG Hai-ying1, SHI Chun-huan1, GAO Xue-de1, CHEN Xiao-yuan1, LI Zhen-qing1, WANG Ji -mei1, ZHANG Cui-fang2
Received:2018-05-29
Revised:2018-05-29
Online:2018-04-20
Published:2018-05-29
CLC Number:
WANG Wei-bo, WANG Hai-ying, SHI Chun-huan, GAO Xue-de, CHEN Xiao-yuan, LI Zhen-qing, WANG Ji -mei, ZHANG Cui-fang. One Case of Toxic Epidermal Necrolysis Induced by Vancomycin Hydrochloride for Injection[J]. Chinese Journal of Pharmacovigilance, 2018, 15(4): 255-256.
Add to citation manager EndNote|Ris|BibTeX
| [1] Tartarone A, Lerose R.Stevens-johnson syndrome and toxic epidermal necrolysis: what do we know[J]. Ther Drug Monit, 2010, 32(6): 669-672. [2] Y eh Y W. Persistent hiccups associated w ith sw itching from risperidone to aripiprazole in a schizophrenic patientw ith cerebral palsy[J]. Clin N europharm acol, 2011, 34(4): 135-136. [3] 吴明东, 丁汀, 魏妙华, 等. 151 例住院患者万古霉素用药分析[J]. 药物流行病学杂志, 2013, 22(1): 7. [4] 孙捍卫, 降文兰, 朱铁梁. 万古霉素的国内应用和不良反应概况[J]. 武警医学院学报, 2009, 18(9): 816-818. [5] Sahai J,Healy D P,Shelton M J, et al.Comparison of vancomycin- and teicoplanin- induced histamine release and red man syndrome[J]. Antimicrob Agents Chemother, 1990, 34(5): 765-769. [6] 黄天国, 宋爱华, 葛英. 万古霉素致红人综合征3例[J]. 临床合理用药杂志, 2013, 6(7): 100-101. [7] 欧燕, 毛艳, 周俊, 等. 万古霉素致严重不良反1例[J]. Herald of Medicine, 2016, 35(9): 1020. [8] 谭慧心. 万古霉素2001-2013年不良反应报道文献的分析[J]. 现代药物与临床, 2013, 28(4): 598-601. [9] 陶宏, 曹国文, 佟光明, 等. 1例万古霉素致药热的会诊案例分析[J]. 华西药学杂志, 2013, 28(6): 654. [10] 褚燕琦, 王之舟, 沈江华, 等. 基于《中国万古霉素治疗药物监测指南》对我院万古霉素药物治疗监测现状评价研究[J]. 中国药物警戒, 2017, 14(7): 435-438. |
| [1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
| [2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
| [3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
| [4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
| [5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
| [6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
| [7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
| [8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
| [9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
| [10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
| [11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
| [12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
| [13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
| [14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
| [15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
